Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBL 12 in untreated asymptomatic myeloma
NCT01096810Phase 2Terminated
- Start
- Sep 2008
- Primary completion
- Mar 2014
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of TBL12 in multiple myeloma (MM). Started Sep 2008; status: terminated.
02
Drugs
TBL12
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01096810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01096810.